# Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

> **NCT00125138** · PHASE2 · COMPLETED · sponsor: **Lundbeck LLC** · enrollment: 90 (actual)

## Conditions studied

- Parkinson's Disease
- Psychotic Disorders

## Interventions

- **DRUG:** Melperone HCl
- **DRUG:** Melperone HCl
- **DRUG:** Melperone HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00125138
- **Lead sponsor:** Lundbeck LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2011-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125138, "Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00125138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*